Methotrexate-Inadequate Response Autoinjector Device Sub Study
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to implement a substudy in approximately 120 rheumatoid
arthritis (RA) subjects to compare the steady-state serum trough concentration (Cminss), Cmax
and area under the curve (AUC) during the dosing interval (TAU) of subcutaneous (SC)
Abatacept injection of 125 mg via the autoinjector and via the BD Hypak™ Physiolis prefilled
syringe.